Utama › Kanser Metastatik › California › Mountain View
Kajian klinikal Kanser Metastatik di Mountain View, CA
25 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Mountain View (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauh
- VA Palo Alto Health Care System, Palo Alto · 5 mi jauh
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Mengambil pesertaFasa 1/2
- Stanford, Palo Alto · 5 mi jauh
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Mengambil pesertaFasa 2/3
- Stanford Cancer Center, Palo Alto · 5 mi jauh
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mi jauh
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Mengambil pesertaFasa 1/2
- Stanford Medicine, Palo Alto · 5 mi jauh
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Mengambil pesertaFasa 1
- Stanford Cancer Institute, Stanford · 5 mi jauh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Mengambil pesertaFasa 1
- Stanford University Medical Center, Stanford · 5 mi jauh
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Mengambil pesertaFasa 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi jauh
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- Stanford Cancer Center, Palo Alto · 5 mi jauh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauh
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
Mengambil pesertaFasa 2
- Stanford University, Palo Alto · 5 mi jauh
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Mengambil pesertaFasa 3
- Research Site, Palo Alto · 5 mi jauh
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute (SCI), Stanford · 5 mi jauh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Mengambil pesertaFasa 1
- Stanford Medicine Cancer Center, Stanford · 5 mi jauh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi jauh
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
Mengambil pesertaFasa 3
- Stanford University School of Medicine, Palo Alto · 5 mi jauh
A Study of LY4175408 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- Stanford Medicine Cancer Center, Stanford · 5 mi jauh
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauh
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Mengambil pesertaFasa 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · 5 mi jauh
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Mengambil pesertaFasa 2/3
- Stanford Cancer Institute, Palo Alto · 5 mi jauh
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Stanford Cancer Institute, Stanford · 5 mi jauh
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Mengambil pesertaFasa 1
- Stanford Cancer Institute, Stanford · 5 mi jauh
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Mengambil pesertaKajian pemerhatian
- VA Palo Alto Healthcare System, Palo Alto · 5 mi jauh
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Stanford Cancer Institute, Palo Alto · 5 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Stanford · 5 mi jauh
Kajian Kanser Metastatik di bandar lain
- Houston, TX104 kajian
- New York City, NY93 kajian
- Nashville, TN70 kajian
- Boston, MA63 kajian
- Los Angeles, CA57 kajian
- St. Louis, MO54 kajian
- Arlington, VA53 kajian
- Philadelphia, PA46 kajian
- Chicago, IL45 kajian
- San Antonio, TX44 kajian
- Washington, DC43 kajian
- Dallas, TX42 kajian
Kajian lain di Mountain View
- Kanser (semua jenis)40 kajian
- Kanser Payudara26 kajian
- Kanser Paru-paru Bukan Sel Kecil21 kajian
- Leukemia Mieloid Akut19 kajian
- Kanser Ovari19 kajian
- Gangguan Spektrum Autisme17 kajian
- Kanser Paru-paru17 kajian
- Kanser Prostat15 kajian
- Kegagalan Jantung15 kajian
- Autisme13 kajian
- Leukemia Limfoblastik Akut13 kajian
- Kanser Kolorektal13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.